493. IRON DEFICIENCY AFTER ONCOLOGICAL ESOPHAGECTOMY AND GASTRECTOMY

Abstract Removal of the entire stomach or parts of it may affect iron absorption and storage. These conditions mainly caused by altering the acid environment, bypassing the duodenal passage during reconstruction or by chronic inflammatory processes. In addition, patients with esophageal or gastric c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diseases of the esophagus 2023-08, Vol.36 (Supplement_2)
Hauptverfasser: Sallakhi, Aria, Baumgartl, Isabella Alexandra, Andresen, Julian Ramin, Khater, Hagar, Gibas, Georg, Medibach, Amadea, Marolt, Cordula, Radlspöck, Wolfgang, Zacherl, Johannes
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_2
container_start_page
container_title Diseases of the esophagus
container_volume 36
creator Sallakhi, Aria
Baumgartl, Isabella Alexandra
Andresen, Julian Ramin
Khater, Hagar
Gibas, Georg
Medibach, Amadea
Marolt, Cordula
Radlspöck, Wolfgang
Zacherl, Johannes
description Abstract Removal of the entire stomach or parts of it may affect iron absorption and storage. These conditions mainly caused by altering the acid environment, bypassing the duodenal passage during reconstruction or by chronic inflammatory processes. In addition, patients with esophageal or gastric cancer often have an iron deficiency preoperatively due to malnutrition, gastrointestinal hemorrhage, or inflammatory processes. Sometimes these iron deficiencies lead to microcytic hypochromic deficiency anemia. Between January 2015 and December 2019, 103 (=66%) esophagectomy patients and 54 (=34%) (sub)total gastrectomy patients were included. Fe, transferrin and ferritin were collected prospectively to be used for retrospective descriptive analysis: preoperatively and three, six, twelve, 18 and 24 months after the operations. The exclusion criteria were: Age below 18, primary bone marrow disease, hereditary forms of anemia, postoperative tumor recurrence, R1/R2 situation. Iron supplementation was not used in the first postoperative year, and thereafter only in cases of a severe iron deficiency. The severity of iron deficiency was classified by ferritin, according to iron deficiency stages I—III. 18% of patients with oncological esophagectomy and 45% of patients with oncological (sub)total gastrectomy have an iron deficiency two years after the operations. This is manifested mainly by pathologically decreased ferritin levels. There is only a significant difference between the groups, with respect to ferritin (p = 0.021) and transferrin levels (p = 0.028), after 2 postoperative years. 75% of esophagectomy patients with iron deficiency were in stage I, 12.5% in stage II and 12.5% in stage III of iron deficiency. 56% of iron deficiency patients with (sub)total gastrectomy were in stage I, 22% in stage II and 22% in stage III. Patients with (sub)total gastrectomy are more likely to have iron deficiency than patients with esophagectomy during the 24-month postoperative follow-up period. Due to the duodenal bypassing in the (sub)total gastrectomy group a higher prevalence of iron deficiency could have been expected. Most patients have storage iron deficiency (= stage I). Only few patients with iron deficiency have the more severe and decompensated form of iron deficiency, iron deficiency anemia (= stage III).
doi_str_mv 10.1093/dote/doad052.274
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_dote_doad052_274</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/dote/doad052.274</oup_id><sourcerecordid>10.1093/dote/doad052.274</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1194-cd98170791a3a2e455554c9372920f4db94064d9ed14381c924af1f5877830523</originalsourceid><addsrcrecordid>eNqFkEFPhEAMhSdGE9fVu0fuBmxnCsMcyTDLkqxgWDx4IshAotGwAT34750N3O2hfU37mvRj7B4hQFDi0Y7fvUuthZAHXNIF2yAR9zmEcOk0cvDjSNE1u5nnDwCUIoo3LCUlAi-vysJLzS7XuSn0q5fsalN5ZaHLQ5nlOjl45lg-75PM6Lp8cvMi9bLkWFdLf8uuhvZz7u_WumUvO1Prvb-6_Q5Rkd9ZFaMEqbAVLe8pdEGdEpIrDgPZN0UQkVW9RRIxdopTO-AQxlLGwr0ltgyWu900zvPUD81pev9qp98GoTlTaM4UmpVC4yg4y8NiGX9O_2__AY0pWA8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>493. IRON DEFICIENCY AFTER ONCOLOGICAL ESOPHAGECTOMY AND GASTRECTOMY</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Sallakhi, Aria ; Baumgartl, Isabella Alexandra ; Andresen, Julian Ramin ; Khater, Hagar ; Gibas, Georg ; Medibach, Amadea ; Marolt, Cordula ; Radlspöck, Wolfgang ; Zacherl, Johannes</creator><creatorcontrib>Sallakhi, Aria ; Baumgartl, Isabella Alexandra ; Andresen, Julian Ramin ; Khater, Hagar ; Gibas, Georg ; Medibach, Amadea ; Marolt, Cordula ; Radlspöck, Wolfgang ; Zacherl, Johannes</creatorcontrib><description>Abstract Removal of the entire stomach or parts of it may affect iron absorption and storage. These conditions mainly caused by altering the acid environment, bypassing the duodenal passage during reconstruction or by chronic inflammatory processes. In addition, patients with esophageal or gastric cancer often have an iron deficiency preoperatively due to malnutrition, gastrointestinal hemorrhage, or inflammatory processes. Sometimes these iron deficiencies lead to microcytic hypochromic deficiency anemia. Between January 2015 and December 2019, 103 (=66%) esophagectomy patients and 54 (=34%) (sub)total gastrectomy patients were included. Fe, transferrin and ferritin were collected prospectively to be used for retrospective descriptive analysis: preoperatively and three, six, twelve, 18 and 24 months after the operations. The exclusion criteria were: Age below 18, primary bone marrow disease, hereditary forms of anemia, postoperative tumor recurrence, R1/R2 situation. Iron supplementation was not used in the first postoperative year, and thereafter only in cases of a severe iron deficiency. The severity of iron deficiency was classified by ferritin, according to iron deficiency stages I—III. 18% of patients with oncological esophagectomy and 45% of patients with oncological (sub)total gastrectomy have an iron deficiency two years after the operations. This is manifested mainly by pathologically decreased ferritin levels. There is only a significant difference between the groups, with respect to ferritin (p = 0.021) and transferrin levels (p = 0.028), after 2 postoperative years. 75% of esophagectomy patients with iron deficiency were in stage I, 12.5% in stage II and 12.5% in stage III of iron deficiency. 56% of iron deficiency patients with (sub)total gastrectomy were in stage I, 22% in stage II and 22% in stage III. Patients with (sub)total gastrectomy are more likely to have iron deficiency than patients with esophagectomy during the 24-month postoperative follow-up period. Due to the duodenal bypassing in the (sub)total gastrectomy group a higher prevalence of iron deficiency could have been expected. Most patients have storage iron deficiency (= stage I). Only few patients with iron deficiency have the more severe and decompensated form of iron deficiency, iron deficiency anemia (= stage III).</description><identifier>ISSN: 1120-8694</identifier><identifier>EISSN: 1442-2050</identifier><identifier>DOI: 10.1093/dote/doad052.274</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>Diseases of the esophagus, 2023-08, Vol.36 (Supplement_2)</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Sallakhi, Aria</creatorcontrib><creatorcontrib>Baumgartl, Isabella Alexandra</creatorcontrib><creatorcontrib>Andresen, Julian Ramin</creatorcontrib><creatorcontrib>Khater, Hagar</creatorcontrib><creatorcontrib>Gibas, Georg</creatorcontrib><creatorcontrib>Medibach, Amadea</creatorcontrib><creatorcontrib>Marolt, Cordula</creatorcontrib><creatorcontrib>Radlspöck, Wolfgang</creatorcontrib><creatorcontrib>Zacherl, Johannes</creatorcontrib><title>493. IRON DEFICIENCY AFTER ONCOLOGICAL ESOPHAGECTOMY AND GASTRECTOMY</title><title>Diseases of the esophagus</title><description>Abstract Removal of the entire stomach or parts of it may affect iron absorption and storage. These conditions mainly caused by altering the acid environment, bypassing the duodenal passage during reconstruction or by chronic inflammatory processes. In addition, patients with esophageal or gastric cancer often have an iron deficiency preoperatively due to malnutrition, gastrointestinal hemorrhage, or inflammatory processes. Sometimes these iron deficiencies lead to microcytic hypochromic deficiency anemia. Between January 2015 and December 2019, 103 (=66%) esophagectomy patients and 54 (=34%) (sub)total gastrectomy patients were included. Fe, transferrin and ferritin were collected prospectively to be used for retrospective descriptive analysis: preoperatively and three, six, twelve, 18 and 24 months after the operations. The exclusion criteria were: Age below 18, primary bone marrow disease, hereditary forms of anemia, postoperative tumor recurrence, R1/R2 situation. Iron supplementation was not used in the first postoperative year, and thereafter only in cases of a severe iron deficiency. The severity of iron deficiency was classified by ferritin, according to iron deficiency stages I—III. 18% of patients with oncological esophagectomy and 45% of patients with oncological (sub)total gastrectomy have an iron deficiency two years after the operations. This is manifested mainly by pathologically decreased ferritin levels. There is only a significant difference between the groups, with respect to ferritin (p = 0.021) and transferrin levels (p = 0.028), after 2 postoperative years. 75% of esophagectomy patients with iron deficiency were in stage I, 12.5% in stage II and 12.5% in stage III of iron deficiency. 56% of iron deficiency patients with (sub)total gastrectomy were in stage I, 22% in stage II and 22% in stage III. Patients with (sub)total gastrectomy are more likely to have iron deficiency than patients with esophagectomy during the 24-month postoperative follow-up period. Due to the duodenal bypassing in the (sub)total gastrectomy group a higher prevalence of iron deficiency could have been expected. Most patients have storage iron deficiency (= stage I). Only few patients with iron deficiency have the more severe and decompensated form of iron deficiency, iron deficiency anemia (= stage III).</description><issn>1120-8694</issn><issn>1442-2050</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkEFPhEAMhSdGE9fVu0fuBmxnCsMcyTDLkqxgWDx4IshAotGwAT34750N3O2hfU37mvRj7B4hQFDi0Y7fvUuthZAHXNIF2yAR9zmEcOk0cvDjSNE1u5nnDwCUIoo3LCUlAi-vysJLzS7XuSn0q5fsalN5ZaHLQ5nlOjl45lg-75PM6Lp8cvMi9bLkWFdLf8uuhvZz7u_WumUvO1Prvb-6_Q5Rkd9ZFaMEqbAVLe8pdEGdEpIrDgPZN0UQkVW9RRIxdopTO-AQxlLGwr0ltgyWu900zvPUD81pev9qp98GoTlTaM4UmpVC4yg4y8NiGX9O_2__AY0pWA8</recordid><startdate>20230830</startdate><enddate>20230830</enddate><creator>Sallakhi, Aria</creator><creator>Baumgartl, Isabella Alexandra</creator><creator>Andresen, Julian Ramin</creator><creator>Khater, Hagar</creator><creator>Gibas, Georg</creator><creator>Medibach, Amadea</creator><creator>Marolt, Cordula</creator><creator>Radlspöck, Wolfgang</creator><creator>Zacherl, Johannes</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20230830</creationdate><title>493. IRON DEFICIENCY AFTER ONCOLOGICAL ESOPHAGECTOMY AND GASTRECTOMY</title><author>Sallakhi, Aria ; Baumgartl, Isabella Alexandra ; Andresen, Julian Ramin ; Khater, Hagar ; Gibas, Georg ; Medibach, Amadea ; Marolt, Cordula ; Radlspöck, Wolfgang ; Zacherl, Johannes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1194-cd98170791a3a2e455554c9372920f4db94064d9ed14381c924af1f5877830523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sallakhi, Aria</creatorcontrib><creatorcontrib>Baumgartl, Isabella Alexandra</creatorcontrib><creatorcontrib>Andresen, Julian Ramin</creatorcontrib><creatorcontrib>Khater, Hagar</creatorcontrib><creatorcontrib>Gibas, Georg</creatorcontrib><creatorcontrib>Medibach, Amadea</creatorcontrib><creatorcontrib>Marolt, Cordula</creatorcontrib><creatorcontrib>Radlspöck, Wolfgang</creatorcontrib><creatorcontrib>Zacherl, Johannes</creatorcontrib><collection>CrossRef</collection><jtitle>Diseases of the esophagus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sallakhi, Aria</au><au>Baumgartl, Isabella Alexandra</au><au>Andresen, Julian Ramin</au><au>Khater, Hagar</au><au>Gibas, Georg</au><au>Medibach, Amadea</au><au>Marolt, Cordula</au><au>Radlspöck, Wolfgang</au><au>Zacherl, Johannes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>493. IRON DEFICIENCY AFTER ONCOLOGICAL ESOPHAGECTOMY AND GASTRECTOMY</atitle><jtitle>Diseases of the esophagus</jtitle><date>2023-08-30</date><risdate>2023</risdate><volume>36</volume><issue>Supplement_2</issue><issn>1120-8694</issn><eissn>1442-2050</eissn><abstract>Abstract Removal of the entire stomach or parts of it may affect iron absorption and storage. These conditions mainly caused by altering the acid environment, bypassing the duodenal passage during reconstruction or by chronic inflammatory processes. In addition, patients with esophageal or gastric cancer often have an iron deficiency preoperatively due to malnutrition, gastrointestinal hemorrhage, or inflammatory processes. Sometimes these iron deficiencies lead to microcytic hypochromic deficiency anemia. Between January 2015 and December 2019, 103 (=66%) esophagectomy patients and 54 (=34%) (sub)total gastrectomy patients were included. Fe, transferrin and ferritin were collected prospectively to be used for retrospective descriptive analysis: preoperatively and three, six, twelve, 18 and 24 months after the operations. The exclusion criteria were: Age below 18, primary bone marrow disease, hereditary forms of anemia, postoperative tumor recurrence, R1/R2 situation. Iron supplementation was not used in the first postoperative year, and thereafter only in cases of a severe iron deficiency. The severity of iron deficiency was classified by ferritin, according to iron deficiency stages I—III. 18% of patients with oncological esophagectomy and 45% of patients with oncological (sub)total gastrectomy have an iron deficiency two years after the operations. This is manifested mainly by pathologically decreased ferritin levels. There is only a significant difference between the groups, with respect to ferritin (p = 0.021) and transferrin levels (p = 0.028), after 2 postoperative years. 75% of esophagectomy patients with iron deficiency were in stage I, 12.5% in stage II and 12.5% in stage III of iron deficiency. 56% of iron deficiency patients with (sub)total gastrectomy were in stage I, 22% in stage II and 22% in stage III. Patients with (sub)total gastrectomy are more likely to have iron deficiency than patients with esophagectomy during the 24-month postoperative follow-up period. Due to the duodenal bypassing in the (sub)total gastrectomy group a higher prevalence of iron deficiency could have been expected. Most patients have storage iron deficiency (= stage I). Only few patients with iron deficiency have the more severe and decompensated form of iron deficiency, iron deficiency anemia (= stage III).</abstract><pub>Oxford University Press</pub><doi>10.1093/dote/doad052.274</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1120-8694
ispartof Diseases of the esophagus, 2023-08, Vol.36 (Supplement_2)
issn 1120-8694
1442-2050
language eng
recordid cdi_crossref_primary_10_1093_dote_doad052_274
source Oxford University Press Journals All Titles (1996-Current)
title 493. IRON DEFICIENCY AFTER ONCOLOGICAL ESOPHAGECTOMY AND GASTRECTOMY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T13%3A58%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=493.%20IRON%20DEFICIENCY%20AFTER%20ONCOLOGICAL%20ESOPHAGECTOMY%20AND%20GASTRECTOMY&rft.jtitle=Diseases%20of%20the%20esophagus&rft.au=Sallakhi,%20Aria&rft.date=2023-08-30&rft.volume=36&rft.issue=Supplement_2&rft.issn=1120-8694&rft.eissn=1442-2050&rft_id=info:doi/10.1093/dote/doad052.274&rft_dat=%3Coup_cross%3E10.1093/dote/doad052.274%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/dote/doad052.274&rfr_iscdi=true